Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human ELN Protein, N-His

Catalog #:   YHD11401 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P15502
Protein length: Gly392-Val645
Overview

Catalog No.

YHD11401

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Gly392-Val645

Predicted molecular weight

24.24 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P15502

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

ELN, Elastin, Tropoelastin

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human ELN
References

Genetic Determinants of Colonic Diverticulosis-A Systematic Review., PMID:40428403

Preparation, fractionation, and characterization of solubilized elastin and comparison of cellular response on fibroblasts and macrophages., PMID:40409629

Genomic and transcriptomic determinants of clinical outcomes in patients with AML and DNMT3A mutations., PMID:40389402

Smooth muscle cells and fibroblasts in the ascending aorta exhibit minor differences between embryonic origins in angiotensin II-driven transcriptional alterations., PMID:40360730

Antisense oligonucleotides directed against App and Rab5 normalized endosomal Rab activity and reversed DS-AD-linked degenerative phenotypes in the Dp16 mouse model of Down syndrome., PMID:40339155

Role of MicroRNAs in Acute Myeloid Leukemia., PMID:40282406

Clinical applicability of the ELN2020 criteria for tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia: insights from a multicenter retrospective study in real-world practice., PMID:40203479

Impact of BCOR/BCORL1 mutation on outcomes of allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients., PMID:40202539

ELN regulates cellular senescence: Emerging hypothesis for a non-canonical role., PMID:40187570

Blood-Based Proteomic Profiling Identifies OSMR as a Novel Biomarker of AML Outcomes., PMID:40179376

Genetic risk in endolysosomal network genes correlates with endolysosomal dysfunction across neural cell types in Alzheimer's disease., PMID:40166227

Toward a rational therapeutic for elastin related disease: Key considerations for elastin based regenerative medicine strategies., PMID:40158781

Comprehensive analysis of tyrosine kinase domain mutations and imatinib resistance in chronic myeloid leukemia patients., PMID:40112623

Effect of NPM1 Mutation Subtype and Co-Mutation Patterns on the Outcomes of Acute Myeloid Leukemia., PMID:40103515

A Deep Dive Into the Potential Antiaging Effects of Colla Corii Asini on the Skin: A Comparative Study., PMID:40012471

Risk-stratified treatment of sonrotoclax with chemotherapy in newly diagnosed acute myeloid leukemia: a study protocol., PMID:40008672

Leukemia-Derived Dendritic Cells Induce Anti-Leukemic Effects Ex Vivo in AML Independently of Patients' Clinical and Biological Features., PMID:40004163

SpectroPipeR-a streamlining post Spectronaut® DIA-MS data analysis R package., PMID:39985446

Benefits of incorporating plant extracts into a commercially available foundation for daily skin use., PMID:39985374

LINC-PINT suppresses the progression of acute myeloid leukemia via miR-767-5p/SUZ12-mediated JAK/STAT signaling pathway., PMID:39978301

Histopathological Comparison and Expression Analysis of COL1A1, COL3A1, and ELN in the Proximal and Distal Ventral Dartos of Patients With Hypospadias: Protocol for Prospective Case-Control Study., PMID:39964742

The expression level of EVI1 and clinical features help to distinguish prognostic heterogeneity in the AML entity with EVI1 overexpression., PMID:39956382

Machine learning-based bulk RNA analysis reveals a prognostic signature of 13 cell death patterns and potential therapeutic target of SMAD3 in acute myeloid leukemia., PMID:39955536

Classification of acute myeloid leukemia based on multi-omics and prognosis prediction value., PMID:39927613

Rapid quantification of intracellular calcium stores reveals effects of membrane micropeptides on SERCA function., PMID:39921961

Changes in Gene Expression of the Extracellular Matrix in Patients with Full-Thickness Rotator Cuff Tears of Varying Sizes., PMID:39912080

Pretransplant MRD does not seem to affect survival in NPM1-mutated AML undergoing allogeneic stem cell transplantation., PMID:39903105

FOXP1 is a Transcription Factor for the Alzheimer's Disease Risk Gene SORL1., PMID:39902677

2024 White Paper on Recent Issues in Bioanalysis: Three Way-Cross Validation; Urine Clinical Analysis; Automated Methods; Regulatory Queries on Plasma Protein Binding; Automated Biospecimen Management; ELN Migration; Ultra-Sensitivity Mass Spectrometry (Part 1A - Recommendations on Advanced Strategies for Mass Spectrometry Assays, Chromatography, Sample Preparation and BMV/Regulated Bioanalysis Part 1B - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV)., PMID:39862144

The clinical features and outcomes of elderly patients with acute myeloid leukemia: a real word research., PMID:39751973

Molecular, clinical, and prognostic implications of RAS pathway alterations in adult acute myeloid leukemia., PMID:39743890

Post-Relapse Outcomes of Older Patients With NPM1-Mutated AML Are Favorable With Allo Transplant in Second Remission., PMID:39740005

Reduced elastin in multiple myeloma niche promotes cell proliferation., PMID:39725193

Effect of the SGLT2 inhibitor ipragliflozin on the expression of genes that regulate skin function., PMID:39710589

Clinical Outcomes of Early WT1 mRNA Reduction After Remission Induction in Newly Diagnosed Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation., PMID:39694194

Reclassification of Acute Myeloid Leukemia According to the 2022 World Health Organization Classification and the International Consensus Classification Using Open-Source Data., PMID:39676421

Construction and validation of a prognostic model based on oxidative stress-related genes in non-small cell lung cancer (NSCLC): predicting patient outcomes and therapy responses., PMID:39669999

Automatic classification of HEp-2 specimens by explainable deep learning and Jensen-Shannon reliability index., PMID:39637573

Is there really an accelerated phase of chronic myeloid leukaemia at presentation?, PMID:39633067

High iASPP (PPP1R13L) expression is an independent predictor of adverse clinical outcome in acute myeloid leukemia (AML)., PMID:39616159

Phenotypic findings associated with variation in elastin., PMID:39604264

Effect of elastin on abnormal proliferation of pulmonary artery smooth muscle cells at an early stage of hypoxic exposure., PMID:39587908

Downregulation of Genes for Skeletal Muscle Extracellular Matrix Components by Cisplatin., PMID:39522978

Evaluation of cosmetic efficacy of lychee seed fermentation liquid., PMID:39480640

[Diagnosis and Risk Stratification of Acute Myeloid Leukemia, Myelodysplasia -Related]., PMID:39479818

Screening and expression validation of key proteins for secondary hair follicle growth in cashmere goats based on iTRAQ quantitative proteomics technology., PMID:39474271

The prognostic significance of genetics in acute myeloid leukemia under venetoclax-based treatment., PMID:39467855

Multiple cell types including melanocytes contribute to elastogenesis in the developing murine aortic valve., PMID:39461968

Cardiovascular Disease May Be Triggered by Gut Microbiota, Microbial Metabolites, Gut Wall Reactions, and Inflammation., PMID:39408963

Reactive oxygen species and aldehyde dehydrogenase 1A as prognosis and theragnostic biomarker in acute myeloid leukaemia patients., PMID:39392121

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human ELN Protein, N-His [YHD11401]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only